| Allograft rejection |
2.22 |
0.00e+0 |
32/38 (84.21%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Graft-versus-host disease |
2.10 |
0.00e+0 |
32/42 (76.19%) |
HLA-DPA1;HLA-DRA;HLA-DPB1;...
|
| Pentose and glucuronate interconversions |
2.08 |
0.00e+0 |
17/34 (50%) |
UGT2B28;UGT2B17;UGT2B15;...
|
| Metabolism of xenobiotics by cytochrome P450 |
2.05 |
0.00e+0 |
49/77 (63.64%) |
UGT2B28;UGT2B17;ADH1C;...
|
| Ascorbate and aldarate metabolism |
2.04 |
0.00e+0 |
15/30 (50%) |
UGT2B28;UGT2B17;UGT2B15;...
|
| Type I diabetes mellitus |
1.97 |
4.64e-3 |
38/43 (88.37%) |
HLA-DPA1;HLA-DRA;HLA-DPB1;...
|
| Primary bile acid biosynthesis |
1.96 |
6.63e-3 |
15/17 (88.24%) |
AMACR;ACOX2;CYP39A1;...
|
| Butanoate metabolism |
1.95 |
5.80e-3 |
23/28 (82.14%) |
HMGCS2;BDH2;EHHADH;...
|
| Autoimmune thyroid disease |
1.93 |
5.16e-3 |
46/53 (86.79%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Porphyrin and chlorophyll metabolism |
1.93 |
4.64e-3 |
23/43 (53.49%) |
UGT2B28;UGT2B17;UGT2B15;...
|
| Intestinal immune network for IgA production |
1.91 |
5.06e-3 |
38/48 (79.17%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Peroxisome |
1.88 |
6.19e-3 |
72/82 (87.8%) |
AMACR;PEX2;CROT;...
|
| Synthesis and degradation of ketone bodies |
1.87 |
8.57e-3 |
9/10 (90%) |
HMGCS2;BDH2;BDH1;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.81 |
9.95e-3 |
84/100 (84%) |
CCL5;CXCL10;CCL19;...
|
| Retinol metabolism |
1.79 |
1.11e-2 |
41/68 (60.29%) |
UGT2B28;UGT2B17;ADH1C;...
|
| Drug metabolism |
1.78 |
1.04e-2 |
78/151 (51.66%) |
UGT2B28;UGT2B17;ADH1C;...
|
| Viral myocarditis |
1.76 |
1.15e-2 |
53/60 (88.33%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Asthma |
1.75 |
1.13e-2 |
25/31 (80.65%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Cell adhesion molecules |
1.72 |
1.66e-2 |
118/148 (79.73%) |
CD40;HLA-DPA1;VCAM1;...
|
| Steroid hormone biosynthesis |
1.71 |
2.04e-2 |
43/61 (70.49%) |
UGT2B28;UGT2B17;UGT2B15;...
|
| Malaria |
1.70 |
2.08e-2 |
44/50 (88%) |
CD40;VCAM1;SDC2;...
|
| Folate biosynthesis |
1.70 |
2.19e-2 |
23/26 (88.46%) |
GGH;MOCS2;GCH1;...
|
| Toxoplasmosis |
1.69 |
2.14e-2 |
103/112 (91.96%) |
CD40;HLA-DPA1;HLA-DRA;...
|
| Antigen processing and presentation |
1.69 |
2.17e-2 |
60/78 (76.92%) |
HLA-DPA1;HLA-DRA;HSPA2;...
|
| Rheumatoid arthritis |
1.69 |
2.12e-2 |
78/93 (83.87%) |
MMP1;CCL5;HLA-DPA1;...
|
| Bile secretion |
1.68 |
2.11e-2 |
68/90 (75.56%) |
UGT2B28;UGT2B17;UGT2B15;...
|
| Glycine, serine and threonine metabolism |
1.65 |
2.79e-2 |
31/40 (77.5%) |
GATM;SDS;CTH;...
|
| Terpenoid backbone biosynthesis |
1.65 |
2.69e-2 |
18/22 (81.82%) |
HMGCS2;IDI1;PCYOX1;...
|
| Oxidative phosphorylation |
1.62 |
3.68e-2 |
93/133 (69.92%) |
NDUFB7;NDUFS4;NDUFA7;...
|
| Spliceosome |
-1.97 |
5.59e-3 |
101/150 (67.33%) |
DDX23;CDC5L;SF3A1;...
|
| Ribosome biogenesis in eukaryotes |
-1.99 |
1.12e-2 |
52/108 (48.15%) |
XPO1;MPHOSPH10;GAR1;...
|
